Related Experiment Video

Updated: May 18, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Novel antimicrobial agents against multi-drug-resistant gram-positive bacteria: an overview

Venetia Giannakaki1, Spiros Miyakis

  • 1The Academic Suite, Level 8, Block C, The Wollongong Hospital, Wollongong NSW 2500, Australia.

Recent Patents on Anti-Infective Drug Discovery
|September 29, 2012
PubMed

Insights

Antimicrobial resistance is a growing threat, with few new antibiotics developed. This review highlights promising novel agents and patents targeting multi-drug resistant Gram-positive bacteria like MRSA and VRE.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial resistance (AMR) poses a significant global health threat, compromising effective treatment of bacterial infections.
  • Emergence of multi-drug resistant (MDR) strains, including Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococci (VRE), and resistant Streptococcus pneumoniae, necessitates urgent solutions.
  • Limited development of new antibiotics in recent decades exacerbates the challenge of combating resistant Gram-positive pathogens.

Purpose of the Study:

  • To review and summarize novel antibacterial agents currently in development for treating Gram-positive multi-resistant pathogens.
  • To discuss recent patents related to the development of new antimicrobial therapies against resistant bacteria.
  • To provide an overview of the pipeline for new antibiotics targeting critical Gram-positive infections.

Main Methods:

  • Literature review of scientific publications and clinical trial databases.
  • Analysis of patent literature concerning novel antibacterial compounds and strategies.
  • Synthesis of information on drug candidates targeting Gram-positive multi-resistant bacteria.

Main Results:

  • Several novel antimicrobial agents are in various stages of clinical development, showing potential against MDR Gram-positive pathogens.
  • Specific classes of compounds and therapeutic strategies are emerging as promising candidates.
  • Relevant patents indicate ongoing innovation in the field of antibacterial drug discovery.

Conclusions:

  • The pipeline for novel antibacterial agents targeting Gram-positive multi-resistant pathogens shows promise, offering hope against the growing threat of AMR.
  • Continued research and development, alongside patentable innovations, are crucial for addressing the urgent need for new antibiotics.
  • This review consolidates key developments, aiding researchers and clinicians in understanding the current landscape of novel antibacterial therapies.

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects06:42

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects

Published on: September 27, 2024

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...